The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Adeno-Associated Virus (AAV) Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Adeno-Associated Virus (AAV) Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1750768

No of Pages : 112

Ask Your Query

Synopsis
The global Adeno-Associated Virus (AAV) Gene Therapy market size was valued at USD 1684.4 million in 2022 and is forecast to a readjusted size of USD 2966.6 million by 2029 with a CAGR of 8.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Adeno-Associated Virus (AAV) Gene Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Adeno-Associated Virus (AAV) Gene Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Adeno-Associated Virus (AAV) Gene Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Adeno-Associated Virus (AAV) Gene Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
  • Global Adeno-Associated Virus (AAV) Gene Therapy market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Adeno-Associated Virus (AAV) Gene Therapy
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Adeno-Associated Virus (AAV) Gene Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Creative Biolabs, Affinia Therapeutics, Spark Therapeutics, AGC Biologics and StrideBio, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Adeno-Associated Virus (AAV) Gene Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Luxturna
  • Zolgensma
  • Others

Market segment by Application

  • Central Nervous System Diseases
  • Ocular Diseases
  • Liver-directed Diseases
  • Other Hereditary Diseases

Market segment by players, this report covers

  • Creative Biolabs
  • Affinia Therapeutics
  • Spark Therapeutics
  • AGC Biologics
  • StrideBio
  • SIRION Biotech
  • Neurophth Biotechnology
  • Belief BioMed
  • BiBo Biopharma Engineering Co., LTD.
  • Beihai Kangcheng
  • PackGene Biotech
  • Sarepta Therapeutics
  • Carbon BioSciences
  • Kelonia Therapeutics
  • Roche
  • Remedium Bio

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Adeno-Associated Virus (AAV) Gene Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Adeno-Associated Virus (AAV) Gene Therapy, with revenue, gross margin and global market share of Adeno-Associated Virus (AAV) Gene Therapy from 2018 to 2023.
Chapter 3, the Adeno-Associated Virus (AAV) Gene Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Adeno-Associated Virus (AAV) Gene Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Adeno-Associated Virus (AAV) Gene Therapy.
Chapter 13, to describe Adeno-Associated Virus (AAV) Gene Therapy research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Adeno-Associated Virus (AAV) Gene Therapy
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Adeno-Associated Virus (AAV) Gene Therapy by Type
1.3.1 Overview: Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Type in 2022
1.3.3 Luxturna
1.3.4 Zolgensma
1.3.5 Others
1.4 Global Adeno-Associated Virus (AAV) Gene Therapy Market by Application
1.4.1 Overview: Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Central Nervous System Diseases
1.4.3 Ocular Diseases
1.4.4 Liver-directed Diseases
1.4.5 Other Hereditary Diseases
1.5 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size & Forecast
1.6 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast by Region
1.6.1 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region, (2018-2029)
1.6.3 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2018-2029)
1.6.4 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2018-2029)
1.6.6 South America Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Creative Biolabs
2.1.1 Creative Biolabs Details
2.1.2 Creative Biolabs Major Business
2.1.3 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.1.4 Creative Biolabs Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Creative Biolabs Recent Developments and Future Plans
2.2 Affinia Therapeutics
2.2.1 Affinia Therapeutics Details
2.2.2 Affinia Therapeutics Major Business
2.2.3 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.2.4 Affinia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Affinia Therapeutics Recent Developments and Future Plans
2.3 Spark Therapeutics
2.3.1 Spark Therapeutics Details
2.3.2 Spark Therapeutics Major Business
2.3.3 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.3.4 Spark Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Spark Therapeutics Recent Developments and Future Plans
2.4 AGC Biologics
2.4.1 AGC Biologics Details
2.4.2 AGC Biologics Major Business
2.4.3 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.4.4 AGC Biologics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 AGC Biologics Recent Developments and Future Plans
2.5 StrideBio
2.5.1 StrideBio Details
2.5.2 StrideBio Major Business
2.5.3 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.5.4 StrideBio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 StrideBio Recent Developments and Future Plans
2.6 SIRION Biotech
2.6.1 SIRION Biotech Details
2.6.2 SIRION Biotech Major Business
2.6.3 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.6.4 SIRION Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 SIRION Biotech Recent Developments and Future Plans
2.7 Neurophth Biotechnology
2.7.1 Neurophth Biotechnology Details
2.7.2 Neurophth Biotechnology Major Business
2.7.3 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.7.4 Neurophth Biotechnology Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Neurophth Biotechnology Recent Developments and Future Plans
2.8 Belief BioMed
2.8.1 Belief BioMed Details
2.8.2 Belief BioMed Major Business
2.8.3 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.8.4 Belief BioMed Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Belief BioMed Recent Developments and Future Plans
2.9 BiBo Biopharma Engineering Co., LTD.
2.9.1 BiBo Biopharma Engineering Co., LTD. Details
2.9.2 BiBo Biopharma Engineering Co., LTD. Major Business
2.9.3 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.9.4 BiBo Biopharma Engineering Co., LTD. Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 BiBo Biopharma Engineering Co., LTD. Recent Developments and Future Plans
2.10 Beihai Kangcheng
2.10.1 Beihai Kangcheng Details
2.10.2 Beihai Kangcheng Major Business
2.10.3 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.10.4 Beihai Kangcheng Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Beihai Kangcheng Recent Developments and Future Plans
2.11 PackGene Biotech
2.11.1 PackGene Biotech Details
2.11.2 PackGene Biotech Major Business
2.11.3 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.11.4 PackGene Biotech Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 PackGene Biotech Recent Developments and Future Plans
2.12 Sarepta Therapeutics
2.12.1 Sarepta Therapeutics Details
2.12.2 Sarepta Therapeutics Major Business
2.12.3 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.12.4 Sarepta Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Sarepta Therapeutics Recent Developments and Future Plans
2.13 Carbon BioSciences
2.13.1 Carbon BioSciences Details
2.13.2 Carbon BioSciences Major Business
2.13.3 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.13.4 Carbon BioSciences Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Carbon BioSciences Recent Developments and Future Plans
2.14 Kelonia Therapeutics
2.14.1 Kelonia Therapeutics Details
2.14.2 Kelonia Therapeutics Major Business
2.14.3 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.14.4 Kelonia Therapeutics Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Kelonia Therapeutics Recent Developments and Future Plans
2.15 Roche
2.15.1 Roche Details
2.15.2 Roche Major Business
2.15.3 Roche Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.15.4 Roche Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Roche Recent Developments and Future Plans
2.16 Remedium Bio
2.16.1 Remedium Bio Details
2.16.2 Remedium Bio Major Business
2.16.3 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Product and Solutions
2.16.4 Remedium Bio Adeno-Associated Virus (AAV) Gene Therapy Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Remedium Bio Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Adeno-Associated Virus (AAV) Gene Therapy Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Adeno-Associated Virus (AAV) Gene Therapy by Company Revenue
3.2.2 Top 3 Adeno-Associated Virus (AAV) Gene Therapy Players Market Share in 2022
3.2.3 Top 6 Adeno-Associated Virus (AAV) Gene Therapy Players Market Share in 2022
3.3 Adeno-Associated Virus (AAV) Gene Therapy Market: Overall Company Footprint Analysis
3.3.1 Adeno-Associated Virus (AAV) Gene Therapy Market: Region Footprint
3.3.2 Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Type Footprint
3.3.3 Adeno-Associated Virus (AAV) Gene Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value and Market Share by Type (2018-2023)
4.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Adeno-Associated Virus (AAV) Gene Therapy Consumption Value Market Share by Application (2018-2023)
5.2 Global Adeno-Associated Virus (AAV) Gene Therapy Market Forecast by Application (2024-2029)
6 North America
6.1 North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2018-2029)
6.2 North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2018-2029)
6.3 North America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
6.3.1 North America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2018-2029)
6.3.2 United States Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
6.3.3 Canada Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
6.3.4 Mexico Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2018-2029)
7.2 Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2018-2029)
7.3 Europe Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
7.3.1 Europe Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2018-2029)
7.3.2 Germany Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
7.3.3 France Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
7.3.5 Russia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
7.3.6 Italy Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Market Size by Region
8.3.1 Asia-Pacific Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Region (2018-2029)
8.3.2 China Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
8.3.3 Japan Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
8.3.4 South Korea Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
8.3.5 India Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
8.3.7 Australia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
9 South America
9.1 South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2018-2029)
9.2 South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2018-2029)
9.3 South America Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
9.3.1 South America Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2018-2029)
9.3.2 Brazil Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
9.3.3 Argentina Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Market Size by Country
10.3.1 Middle East & Africa Adeno-Associated Virus (AAV) Gene Therapy Consumption Value by Country (2018-2029)
10.3.2 Turkey Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
10.3.4 UAE Adeno-Associated Virus (AAV) Gene Therapy Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Adeno-Associated Virus (AAV) Gene Therapy Market Drivers
11.2 Adeno-Associated Virus (AAV) Gene Therapy Market Restraints
11.3 Adeno-Associated Virus (AAV) Gene Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Adeno-Associated Virus (AAV) Gene Therapy Industry Chain
12.2 Adeno-Associated Virus (AAV) Gene Therapy Upstream Analysis
12.3 Adeno-Associated Virus (AAV) Gene Therapy Midstream Analysis
12.4 Adeno-Associated Virus (AAV) Gene Therapy Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock